Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pulmonx (LUNG) Equity Ratio (2019 - 2025)

Historic Equity Ratio for Pulmonx (LUNG) over the last 7 years, with Q3 2025 value amounting to 0.43.

  • Pulmonx's Equity Ratio fell 2262.43% to 0.43 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.43, marking a year-over-year decrease of 2262.43%. This contributed to the annual value of 0.53 for FY2024, which is 2082.45% down from last year.
  • According to the latest figures from Q3 2025, Pulmonx's Equity Ratio is 0.43, which was down 2262.43% from 0.47 recorded in Q2 2025.
  • In the past 5 years, Pulmonx's Equity Ratio registered a high of 0.85 during Q1 2021, and its lowest value of 0.43 during Q3 2025.
  • For the 5-year period, Pulmonx's Equity Ratio averaged around 0.69, with its median value being 0.69 (2023).
  • As far as peak fluctuations go, Pulmonx's Equity Ratio surged by 12829.84% in 2021, and later crashed by 2325.45% in 2025.
  • Over the past 5 years, Pulmonx's Equity Ratio (Quarter) stood at 0.82 in 2021, then fell by 3.23% to 0.8 in 2022, then dropped by 16.31% to 0.67 in 2023, then decreased by 20.82% to 0.53 in 2024, then dropped by 17.61% to 0.43 in 2025.
  • Its last three reported values are 0.43 in Q3 2025, 0.47 for Q2 2025, and 0.52 during Q1 2025.